The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. (Q52954955)
Jump to navigation
Jump to search
scientific article published in October 2002
- The impact of the polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. |
scientific article published in October 2002 |
|
Statements
The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. (English)
1 reference
Bruno Müller-Oerlinghausen
1 reference
Jürgen Brockmöller
1 reference
Julia Kirchheiner
1 reference
Jürgen Schmider
1 reference
Silke Walter
1 reference
Christoph Sachse
1 reference
Ivar Roots
1 reference
1 October 2002
1 reference
72
1 reference
438-452
1 reference
4
1 reference